4.5 Article

Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Relevance of circulating MiRNA-21 and MiRNA-181 in prediction of glioblastoma multiforme prognosis

Esraa M. Labib et al.

Summary: The study revealed that miR-21 was up-regulated and miR-181 was down-regulated in GBM patients, with their expression levels associated with patient age and tumor characteristics, as well as impacting patient prognosis. Detection of miR-21 and miR-181 expression levels may serve as potential diagnostic and prognostic factors for GBM.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)

Article Biotechnology & Applied Microbiology

Treatment Patterns and Outcomes Among Elderly Glioblastoma Patients in Riyadh, Saudi Arabia

Amal Marie et al.

Summary: Management of elderly patients with GBM is controversial. The study found that conventional radiotherapy and completion of adjuvant chemotherapy were associated with better overall survival (OS), while early start of adjuvant treatment and completion of adjuvant chemotherapy were associated with better progression-free survival (PFS).

ONCOTARGETS AND THERAPY (2022)

Article Genetics & Heredity

Targeted next generation sequencing provides insight for the genetic alterations in liquid biopsy of Egyptian brain tumor patients

Neemat M. Kassem et al.

Summary: This study utilizes next generation sequencing technology to analyze the genetic alterations in liquid biopsy of newly diagnosed GBM patients. The results reveal the presence of gene mutations and microsatellite instability changes, which may have important implications for improving treatment outcomes and developing personalized therapies.

EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS (2022)

Article Biochemistry & Molecular Biology

Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis

Menha Swellam et al.

Summary: The study aimed to investigate the role of miR-17-5p, miR-125b, and miR-221 in glioblastoma multiforme (GBM) patients, and found that their expression levels were associated with clinical characteristics and survival patterns. Analysis of these miRs may serve as a helpful tool in predicting prognosis and treatment response for GBM patients.

JOURNAL OF MOLECULAR NEUROSCIENCE (2021)

Article Oncology

Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients

Menha Swellam et al.

Summary: Research has shown that lncRNAs XIST and NEAT1 are significantly upregulated in high-risk breast cancer patients and are associated with different characteristics of the cancer, with NEAT1 displaying higher sensitivity in detecting high-risk factors.

CURRENT PROBLEMS IN CANCER (2021)

Review Cell Biology

Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential

Yi Wang et al.

Summary: In the past two decades, ncRNAs, especially miRNAs, lncRNAs, and circRNAs, have been found to play important roles in ischemic heart disease, participating in the process of cardiac recovery. Studies have shown that at least five miRNAs have therapeutic potential in large animal models, with favorable outcomes. Furthermore, the functional roles of lncRNAs and circRNAs are also being explored in cardiac regeneration.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma

Omidvar Rezaei et al.

Summary: Glioblastoma is an aggressive diffuse kind of glioma, with poor survival rate and associated with genetic aberrations and somatic mutations. Studies have underscored the impact of long non-coding RNAs in glioblastoma, with certain lncRNAs playing key roles in the pathogenesis of the disease.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries

Ljupcho Efremov et al.

Summary: This study analyzed 40,138 adult GBM cases diagnosed in Germany between 1999 and 2014, finding that younger age, female sex, surgical resection, and the use of radiotherapy and chemotherapy were associated with better survival outcomes. The inclusion of temozolomide chemotherapy significantly improved median OS in older age groups but had a lesser effect in younger age groups. Survival improvements were observed over time for each treatment option.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Review Genetics & Heredity

Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma

Parvaneh Mahinfar et al.

Summary: This article reviews the contribution of long non-coding RNAs (lncRNAs) to the regulation of multidrug resistance (MDR) and elucidates the underlying mechanisms in glioblastoma, offering new avenues for the treatment of this aggressive brain tumor.
Review Oncology

Long, Noncoding RNA Dysregulation in Glioblastoma

Patrick A. DeSouza et al.

Summary: Developing effective therapies for GBM is challenging due to tumor heterogeneity and therapeutic resistance. Understanding the mechanisms and impact of long noncoding RNAs is crucial for improving management and outcomes in this aggressive brain cancer.

CANCERS (2021)

Review Medicine, Research & Experimental

LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics

Bhupender Yadav et al.

Summary: This review discusses the specific involvement of long non-coding RNAs in the pathogenesis of glioblastoma multiforme, focusing on their association with key molecular and cellular regulatory mechanisms. Novel RNA-based strategies for therapeutic purposes are also highlighted.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Oncology

Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review

Sara Momtazmanesh et al.

Summary: Glioma, the most common malignant central nervous system tumor, presents challenges due to incomplete understanding of molecular pathways in tumor progression. Long non-coding RNAs (lncRNAs) are implicated in various stages of glioma development and hold potential for diagnostic and therapeutic applications. Evaluating lncRNAs' roles in tumor progression, molecular pathways, and clinical relevance is essential for advancing novel therapeutic strategies.

FRONTIERS IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments

Sally L. Perrin et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2019)

Article Biotechnology & Applied Microbiology

Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6

Mi Gong et al.

ONCOTARGETS AND THERAPY (2019)

Article Biochemistry & Molecular Biology

LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade

Zhijia Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Biochemistry & Molecular Biology

Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets

Marek Vecera et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Oncology

Regulation of lncRNA and Its Role in Cancer Metastasis

Juan Li et al.

ONCOLOGY RESEARCH (2016)

Article Neurosciences

A long non-coding RNA signature in glioblastoma multiforme predicts survival

Xiao-Qin Zhang et al.

NEUROBIOLOGY OF DISEASE (2013)